TransMedics Group Past Earnings Performance
Past criteria checks 0/6
TransMedics Group has been growing earnings at an average annual rate of 2.5%, while the Medical Equipment industry saw earnings growing at 8.7% annually. Revenues have been growing at an average rate of 58.3% per year.
Key information
2.5%
Earnings growth rate
60.1%
EPS growth rate
| Medical Equipment Industry Growth | 8.9% |
| Revenue growth rate | 58.3% |
| Return on equity | -6.4% |
| Net Margin | -3.4% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Recent updates
TransMedics Group (NASDAQ:TMDX) Might Have The Makings Of A Multi-Bagger
Jun 10
TransMedics: Transportation Supporting Growth
May 21TransMedics Group: Looking At The Road Ahead After An Exceptional Q1 (Rating Downgrade)
May 06TransMedics Group, Inc. (NASDAQ:TMDX) Stocks Shoot Up 27% But Its P/S Still Looks Reasonable
Apr 24TransMedics Group: Founder Led Company With Solid Potential
Apr 19Is TransMedics Group (NASDAQ:TMDX) Using Too Much Debt?
Apr 11TransMedics Group: Emerging Medical Device Market Leader With A Long Growth Runway
Mar 19TransMedics Group: Huge Opportunity In Organ Transplants
Mar 12TransMedics: A Very Expensive Growth Stock
Feb 07With TransMedics Group, Inc. (NASDAQ:TMDX) It Looks Like You'll Get What You Pay For
Jan 23Calculating The Fair Value Of TransMedics Group, Inc. (NASDAQ:TMDX)
Jan 02Does TransMedics Group (NASDAQ:TMDX) Have A Healthy Balance Sheet?
Nov 05This Just In: Analysts Are Boosting Their TransMedics Group, Inc. (NASDAQ:TMDX) Outlook for This Year
Aug 06TransMedics Group (NASDAQ:TMDX) Has Debt But No Earnings; Should You Worry?
Aug 02TransMedics Group, Inc. (NASDAQ:TMDX) Not Lagging Industry On Growth Or Pricing
Jun 29Brokers Are Upgrading Their Views On TransMedics Group, Inc. (NASDAQ:TMDX) With These New Forecasts
May 06Is TransMedics Group (NASDAQ:TMDX) Using Too Much Debt?
Apr 27Estimating The Intrinsic Value Of TransMedics Group, Inc. (NASDAQ:TMDX)
Apr 09Is TransMedics Group (NASDAQ:TMDX) A Risky Investment?
Jan 16TransMedics: Game Changer Technology Will Boost Revenue Growth
Oct 20TransMedics Is A Buy Following Q2 FY22 Earnings Upside
Aug 03Revenue & Expenses Breakdown
How TransMedics Group makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 297 | -10 | 129 | 42 |
| 31 Dec 23 | 242 | -25 | 118 | 36 |
| 30 Sep 23 | 192 | -36 | 107 | 31 |
| 30 Jun 23 | 151 | -18 | 93 | 27 |
| 31 Mar 23 | 119 | -28 | 81 | 25 |
| 31 Dec 22 | 93 | -36 | 70 | 27 |
| 30 Sep 22 | 72 | -42 | 60 | 27 |
| 30 Jun 22 | 51 | -48 | 54 | 26 |
| 31 Mar 22 | 39 | -47 | 45 | 25 |
| 31 Dec 21 | 30 | -44 | 38 | 22 |
| 30 Sep 21 | 28 | -38 | 32 | 21 |
| 30 Jun 21 | 30 | -30 | 28 | 20 |
| 31 Mar 21 | 25 | -28 | 24 | 17 |
| 31 Dec 20 | 26 | -29 | 24 | 19 |
| 30 Sep 20 | 24 | -32 | 24 | 21 |
| 30 Jun 20 | 24 | -35 | 25 | 21 |
| 31 Mar 20 | 26 | -36 | 26 | 22 |
| 28 Dec 19 | 24 | -34 | 24 | 20 |
| 28 Sep 19 | 21 | -32 | 22 | 17 |
| 29 Jun 19 | 18 | -29 | 18 | 15 |
| 30 Mar 19 | 15 | -26 | 15 | 14 |
| 29 Dec 18 | 13 | -24 | 12 | 14 |
| 29 Sep 18 | 12 | -21 | 10 | 14 |
| 30 Jun 18 | 9 | -20 | 9 | 14 |
| 31 Mar 18 | 8 | -20 | 8 | 14 |
| 30 Dec 17 | 8 | -21 | 8 | 15 |
| 31 Dec 16 | 6 | -24 | 8 | 16 |
Quality Earnings: TMDX is currently unprofitable.
Growing Profit Margin: TMDX is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: TMDX is unprofitable, but has reduced losses over the past 5 years at a rate of 2.5% per year.
Accelerating Growth: Unable to compare TMDX's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: TMDX is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (2.4%).
Return on Equity
High ROE: TMDX has a negative Return on Equity (-6.39%), as it is currently unprofitable.